找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊ONCOLOGY(腫瘤學)版塊期刊總數:242)
新窗
投票 SCIE期刊BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 2024/2025影響因子:9.725 (BBA-REV CANCER) (0304-419X). (ONCOLOGY)(腫瘤學)  ...234
Total Citations:9799; 2023 JIF:9.725; JIFRank: 29/322 ; Rank-JIF: 29; Number-of-JIF:322; 5 Year JIF:11.263; 5 Year JIF Quartile:Q1; JIF Without Self Cites:9.6; Immediacy Index:1.1; Immediacy Index-dealt:1.165; 2023 JCI:1.33; JCI Rank: 50/322 ; Total Articles:5; JCI Quartile:Q1; JCI Percentile:94.16; Eigenfactor:0.011; Normalized Eigenfactor:2.348; Article Influence Score:2.469; JIF Percentile:94.2; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:161; % of Articles in Citable items:0.0311; Cited Half-Life:4.4; Citing Half-Life:6.1; % of OA Gold:0.2222; Publisher name:BMJ PUBLISHING GROUP; Publisher address:BRITISH MED ASSOC HOUSE, TAVISTOCK SQ
投票 SCIE期刊JOURNAL OF CLINICAL ONCOLOGY 2024/2025影響因子:42.193 (J CLIN ONCOL) (0732-183X). (ONCOLOGY)(腫瘤學)Science Citation Ind  ...234
Total Citations:169257; 2023 JIF:42.193; JIFRank: 6/322 ; Rank-JIF: 6; Number-of-JIF:322; 5 Year JIF:37.478; 5 Year JIF Quartile:Q1; JIF Without Self Cites:41.1; Immediacy Index:13; Immediacy Index-dealt:13.137; 2023 JCI:6.46; JCI Rank: 8/322 ; Total Articles:464; JCI Quartile:Q1; JCI Percentile:97.67; Eigenfactor:0.21; Normalized Eigenfactor:45.975; Article Influence Score:15.561; JIF Percentile:98.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:479; % of Articles in Citable items:0.9687; Cited Half-Life:8; Citing Half-Life:6.5; % of OA Gold:0.2996; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊MOLECULAR CANCER THERAPEUTICS 2024/2025影響因子:5.386 (MOL CANCER THER) (1535-7163). (ONCOLOGY)(腫瘤學)Science Citation  ...234
Total Citations:18993; 2023 JIF:5.386; JIFRank: 61/322 ; Rank-JIF: 61; Number-of-JIF:322; 5 Year JIF:5.447; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.3; Immediacy Index:1.2; Immediacy Index-dealt:1.285; 2023 JCI:1.23; JCI Rank: 58/322 ; Total Articles:104; JCI Quartile:Q1; JCI Percentile:82.14; Eigenfactor:0.016; Normalized Eigenfactor:3.426; Article Influence Score:1.727; JIF Percentile:81.2; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:116; % of Articles in Citable items:0.8966; Cited Half-Life:8.6; Citing Half-Life:7.1; % of OA Gold:0.3275; Publisher name:VERLAG OTTO HARRASSOWITZ; Publisher address:TAUMUSSTR 14,, WIESBADEN, GERMA
投票 SCIE期刊CLINICAL ONCOLOGY 2024/2025影響因子:3.252 (CLIN ONCOL-UK) (0936-6555). (ONCOLOGY)(腫瘤學)Science Citation Index Expanded  ...234
Total Citations:4268; 2023 JIF:3.252; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:3.393; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:1; Immediacy Index-dealt:1.150; 2023 JCI:0.68; JCI Rank: 151/322 ; Total Articles:117; JCI Quartile:Q2; JCI Percentile:53.26; Eigenfactor:0.005; Normalized Eigenfactor:1.055; Article Influence Score:1.048; JIF Percentile:60.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:132; % of Articles in Citable items:0.8864; Cited Half-Life:6.6; Citing Half-Life:6.4; % of OA Gold:0.204; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United
投票 SCIE期刊Onkologie 2024/2025影響因子:0.249 (ONKOLOGIE-GER) (2731-7226). (ONCOLOGY)(腫瘤學)Science Citation Index Expanded  ...234
Total Citations:233; 2023 JIF:0.249; JIFRank: 315/322 ; Rank-JIF: 315; Number-of-JIF:322; 5 Year JIF:0.244; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:0.1; Immediacy Index-dealt:0.115; 2023 JCI:0.07; JCI Rank: 311/322 ; Total Articles:103; JCI Quartile:Q4; JCI Percentile:3.57; Eigenfactor:0; Normalized Eigenfactor:0.049; Article Influence Score:0.042; JIF Percentile:2.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:111; % of Articles in Citable items:0.9279; Cited Half-Life:4.5; Citing Half-Life:5.5; % of OA Gold:0.0941; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 SCIE期刊Molecular Cancer 2024/2025影響因子:27.743 (MOL CANCER) (NULL). (ONCOLOGY)(腫瘤學)Science Citation Index Expanded  ...234
Total Citations:36560; 2023 JIF:27.743; JIFRank: 10/322 ; Rank-JIF: 10; Number-of-JIF:322; 5 Year JIF:31.343; 5 Year JIF Quartile:Q1; JIF Without Self Cites:27.1; Immediacy Index:6; Immediacy Index-dealt:6.198; 2023 JCI:5.26; JCI Rank: 9/322 ; Total Articles:81; JCI Quartile:Q1; JCI Percentile:97.36; Eigenfactor:0.047; Normalized Eigenfactor:10.323; Article Influence Score:6.95; JIF Percentile:97; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:165; % of Articles in Citable items:0.4909; Cited Half-Life:4.3; Citing Half-Life:5.1; % of OA Gold:1; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LANE, KIDL
投票 SCIE期刊European Journal of Oncology Nursing 2024/2025影響因子:2.701 (EUR J ONCOL NURS) (1462-3889). (ONCOLOGY)(腫瘤學)Science C  ...234
Total Citations:3808; 2023 JIF:2.701; JIFRank: 163/322 ; Rank-JIF: 163; Number-of-JIF:322; 5 Year JIF:3.157; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.5; Immediacy Index:0.5; Immediacy Index-dealt:0.581; 2023 JCI:0.98; JCI Rank: 81/322 ; Total Articles:164; JCI Quartile:Q2; JCI Percentile:74.08; Eigenfactor:0.004; Normalized Eigenfactor:0.766; Article Influence Score:0.77; JIF Percentile:87.7; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:185; % of Articles in Citable items:0.8865; Cited Half-Life:6.7; Citing Half-Life:6.2; % of OA Gold:0.2181; Publisher name:EDINBURGH UNIV PRESS; Publisher address:THE TUN-HOLYROOD RD, 12 2F JACKSONS
投票 SCIE期刊BONE MARROW TRANSPLANTATION 2024/2025影響因子:4.585 (BONE MARROW TRANSPL) (0268-3369). (ONCOLOGY)(腫瘤學)Science Citatio  ...234
Total Citations:14809; 2023 JIF:4.585; JIFRank: 78/322 ; Rank-JIF: 78; Number-of-JIF:322; 5 Year JIF:4.577; 5 Year JIF Quartile:Q2; JIF Without Self Cites:4.2; Immediacy Index:0.9; Immediacy Index-dealt:0.944; 2023 JCI:0.9; JCI Rank: 91/322 ; Total Articles:118; JCI Quartile:Q2; JCI Percentile:72.1; Eigenfactor:0.013; Normalized Eigenfactor:2.76; Article Influence Score:1.443; JIF Percentile:66.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:128; % of Articles in Citable items:0.9219; Cited Half-Life:10; Citing Half-Life:6.5; % of OA Gold:0.235; Publisher name:CENTRE NATL RECHERCHE SCIENTIFIQUE, CENTRE RECHERCHES HISTORIQUES; Publisher add
投票 SCIE期刊Cancer Discovery 2024/2025影響因子:29.758 (CANCER DISCOV) (2159-8274). (ONCOLOGY)(腫瘤學)Science Citation Index Expanded  ...234
Total Citations:33545; 2023 JIF:29.758; JIFRank: 8/322 ; Rank-JIF: 8; Number-of-JIF:322; 5 Year JIF:32.401; 5 Year JIF Quartile:Q1; JIF Without Self Cites:29.4; Immediacy Index:6.7; Immediacy Index-dealt:6.716; 2023 JCI:6.62; JCI Rank: 7/322 ; Total Articles:106; JCI Quartile:Q1; JCI Percentile:97.98; Eigenfactor:0.073; Normalized Eigenfactor:15.918; Article Influence Score:14.382; JIF Percentile:97.7; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:117; % of Articles in Citable items:0.906; Cited Half-Life:4.8; Citing Half-Life:6; % of OA Gold:0.3696; Publisher name:ELSEVIER SCI LTD; Publisher address:125 London Wall, London, England, EC2Y 5
投票 SCIE期刊JOURNAL OF IMMUNOTHERAPY 2024/2025影響因子:3.216 (J IMMUNOTHER) (1524-9557). (ONCOLOGY)(腫瘤學)Science Citation Index Ex  ...234
Total Citations:3156; 2023 JIF:3.216; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:3.617; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.8; Immediacy Index-dealt:0.858; 2023 JCI:0.82; JCI Rank: 109/322 ; Total Articles:38; JCI Quartile:Q2; JCI Percentile:65.87; Eigenfactor:0.002; Normalized Eigenfactor:0.536; Article Influence Score:1.179; JIF Percentile:57.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:44; % of Articles in Citable items:0.8636; Cited Half-Life:11.2; Citing Half-Life:5.6; % of OA Gold:0.2585; Publisher name:IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC; Publisher address:445 HOES
投票 SCIE期刊UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 2024/2025影響因子:2.403 (UROL ONCOL-SEMIN ORI) (1078-1439). (O  ...234
Total Citations:6969; 2023 JIF:2.403; JIFRank: 193/322 ; Rank-JIF: 193; Number-of-JIF:322; 5 Year JIF:2.577; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.6; Immediacy Index-dealt:0.634; 2023 JCI:0.75; JCI Rank: 130/322 ; Total Articles:224; JCI Quartile:Q2; JCI Percentile:62.3; Eigenfactor:0.009; Normalized Eigenfactor:2.032; Article Influence Score:0.778; JIF Percentile:63.9; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:245; % of Articles in Citable items:0.9143; Cited Half-Life:5.5; Citing Half-Life:6.3; % of OA Gold:0.11; Publisher name:MALAYSIAN ENGLISH LANGUAGE TEACHING ASSOC; Publisher address:G-11-2, PUTRA W
投票 SCIE期刊JACC: CardioOncology 2024/2025影響因子:12.101 (JACC-CARDIOONCOL) (2666-0873). (ONCOLOGY)(腫瘤學)Science Citation Index E  ...234
Total Citations:1975; 2023 JIF:12.101; JIFRank: 22/322 ; Rank-JIF: 22; Number-of-JIF:322; 5 Year JIF:11.794; 5 Year JIF Quartile:Q1; JIF Without Self Cites:11.4; Immediacy Index:2.8; Immediacy Index-dealt:2.884; 2023 JCI:2.12; JCI Rank: 25/322 ; Total Articles:43; JCI Quartile:Q1; JCI Percentile:92.39; Eigenfactor:0.005; Normalized Eigenfactor:1.175; Article Influence Score:4.159; JIF Percentile:93.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:52; % of Articles in Citable items:0.8269; Cited Half-Life:2.6; Citing Half-Life:5.4; % of OA Gold:0.9028; Publisher name:EMERALD GROUP PUBLISHING LTD; Publisher address:Floor 5, Northspring 21-23
投票 SCIE期刊Recent Patents on Anti-Cancer Drug Discovery 2024/2025影響因子:2.558 (RECENT PAT ANTI-CANC) (1574-8928). (ONCOLOGY)(腫  ...234
Total Citations:999; 2023 JIF:2.558; JIFRank: 183/322 ; Rank-JIF: 183; Number-of-JIF:322; 5 Year JIF:2.619; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.4; Immediacy Index:2.1; Immediacy Index-dealt:2.171; 2023 JCI:0.5; JCI Rank: 208/322 ; Total Articles:16; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.001; Normalized Eigenfactor:0.125; Article Influence Score:0.436; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:38; % of Articles in Citable items:0.4211; Cited Half-Life:6; Citing Half-Life:6; % of OA Gold:0; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND
投票 SCIE期刊Cancer Communications 2024/2025影響因子:20.136 (CANCER COMMUN) (NULL). (ONCOLOGY)(腫瘤學)Science Citation Index Expanded  ...234
Total Citations:5020; 2023 JIF:20.136; JIFRank: 14/322 ; Rank-JIF: 14; Number-of-JIF:322; 5 Year JIF:16.783; 5 Year JIF Quartile:Q1; JIF Without Self Cites:19.8; Immediacy Index:2.1; Immediacy Index-dealt:2.178; 2023 JCI:3.06; JCI Rank: 16/322 ; Total Articles:40; JCI Quartile:Q1; JCI Percentile:95.19; Eigenfactor:0.01; Normalized Eigenfactor:2.125; Article Influence Score:3.977; JIF Percentile:95.8; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:46; % of Articles in Citable items:0.8696; Cited Half-Life:2.9; Citing Half-Life:5.4; % of OA Gold:0.6532; Publisher name:INT STATISTICAL INST; Publisher address:428 PRINSES BEATRIXLAAN, VOORBURG, N
投票 SCIE期刊Expert Review of Anticancer Therapy 2024/2025影響因子:2.953 (EXPERT REV ANTICANC) (1473-7140). (ONCOLOGY)(腫瘤學)Science  ...234
Total Citations:4255; 2023 JIF:2.953; JIFRank: 151/322 ; Rank-JIF: 151; Number-of-JIF:322; 5 Year JIF:4.126; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.8; Immediacy Index-dealt:0.814; 2023 JCI:0.46; JCI Rank: 220/322 ; Total Articles:35; JCI Quartile:Q3; JCI Percentile:31.83; Eigenfactor:0.004; Normalized Eigenfactor:0.806; Article Influence Score:0.929; JIF Percentile:53.3; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:108; % of Articles in Citable items:0.3241; Cited Half-Life:6.4; Citing Half-Life:5.1; % of OA Gold:0.1086; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, US
投票 SCIE期刊Therapeutic Advances in Medical Oncology 2024/2025影響因子:4.323 (THER ADV MED ONCOL) (1758-8340). (ONCOLOGY)(腫瘤學)Sci  ...234
Total Citations:4724; 2023 JIF:4.323; JIFRank: 88/322 ; Rank-JIF: 88; Number-of-JIF:322; 5 Year JIF:4.934; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:0.8; Immediacy Index-dealt:0.865; 2023 JCI:0.81; JCI Rank: 113/322 ; Total Articles:107; JCI Quartile:Q2; JCI Percentile:65.06; Eigenfactor:0.009; Normalized Eigenfactor:1.867; Article Influence Score:1.398; JIF Percentile:72.8; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:194; % of Articles in Citable items:0.5515; Cited Half-Life:3.7; Citing Half-Life:4.9; % of OA Gold:0.8969; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAM
投票 SCIE期刊American Journal of Translational Research 2024/2025影響因子:1.775 (AM J TRANSL RES) (1943-8141). (ONCOLOGY)(腫瘤學)Scie  ...234
Total Citations:12773; 2023 JIF:1.775; JIFRank: 250/322 ; Rank-JIF: 250; Number-of-JIF:322; 5 Year JIF:2.378; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.2; Immediacy Index-dealt:0.298; 2023 JCI:0.44; JCI Rank: 229/322 ; Total Articles:624; JCI Quartile:Q3; JCI Percentile:29.04; Eigenfactor:0.015; Normalized Eigenfactor:3.2; Article Influence Score:0.454; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:661; % of Articles in Citable items:0.944; Cited Half-Life:4.3; Citing Half-Life:5.2; % of OA Gold:0.0007; Publisher name:UNIV COSTA RICA; Publisher address:CENTRO INVESTIGACIONES AGRONOMICAS, APDO
投票 SCIE期刊Cancer & Metabolism 2024/2025影響因子:6.143 (CANCER METAB) (NULL). (ONCOLOGY)(腫瘤學)Science Citation Index Expanded  ...234
Total Citations:1467; 2023 JIF:6.143; JIFRank: 51/322 ; Rank-JIF: 51; Number-of-JIF:322; 5 Year JIF:5.459; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6; Immediacy Index:0.7; Immediacy Index-dealt:0.735; 2023 JCI:1.04; JCI Rank: 74/322 ; Total Articles:26; JCI Quartile:Q1; JCI Percentile:77.17; Eigenfactor:0.002; Normalized Eigenfactor:0.328; Article Influence Score:1.447; JIF Percentile:84.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:26; % of Articles in Citable items:1; Cited Half-Life:6.3; Citing Half-Life:6.3; % of OA Gold:1; Publisher name:PEETERS; Publisher address:BONDGENOTENLAAN 153, LEUVEN, BELGIUM, B-3000;
投票 SCIE期刊Cancers 2024/2025影響因子:4.574 (CANCERS) (NULL). (ONCOLOGY)(腫瘤學)Science Citation Index Expanded  ...234
Total Citations:102352; 2023 JIF:4.574; JIFRank: 78/322 ; Rank-JIF: 78; Number-of-JIF:322; 5 Year JIF:4.986; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4; Immediacy Index:1; Immediacy Index-dealt:1.145; 2023 JCI:0.9; JCI Rank: 91/322 ; Total Articles:3697; JCI Quartile:Q2; JCI Percentile:71.89; Eigenfactor:0.177; Normalized Eigenfactor:38.686; Article Influence Score:1.146; JIF Percentile:75.9; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:5643; % of Articles in Citable items:0.6551; Cited Half-Life:2.7; Citing Half-Life:6.3; % of OA Gold:0.9952; Publisher name:COIMBRA UNIV PRESS; Publisher address:RUA DA ILHA, NO 1, COIMBRA, PORTUGAL,
投票 SCIE期刊INTEGRATIVE CANCER THERAPIES 2024/2025影響因子:2.948 (INTEGR CANCER THER) (1534-7354). (ONCOLOGY)(腫瘤學)Science Citatio  ...234
Total Citations:3286; 2023 JIF:2.948; JIFRank: 151/322 ; Rank-JIF: 151; Number-of-JIF:322; 5 Year JIF:3.451; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.2; Immediacy Index-dealt:0.223; 2023 JCI:0.65; JCI Rank: 164/322 ; Total Articles:72; JCI Quartile:Q3; JCI Percentile:49.22; Eigenfactor:0.004; Normalized Eigenfactor:0.77; Article Influence Score:0.773; JIF Percentile:53.3; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:90; % of Articles in Citable items:0.8; Cited Half-Life:5.5; Citing Half-Life:7.1; % of OA Gold:0.9225; Publisher name:DUKE UNIV PRESS; Publisher address:905 W MAIN ST, STE 18-B, DURHAM, USA, NC, 27
下一頁 »
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-4 20:45
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
返回頂部 返回版塊
元阳县| 罗平县| 集安市| 永兴县| 浦东新区| 尤溪县| 洱源县| 晋宁县| 荆州市| 科尔| 固阳县| 惠州市| 尚志市| 定边县| 滁州市| 新田县| 绥棱县| 临泉县| 乌兰县| 蓬安县| 西盟| 任丘市| 孟连| 宁乡县| 宣汉县| 龙里县| 信阳市| 涞源县| 博爱县| 容城县| 白城市| 张家界市| 都安| 东至县| 宁陵县| 随州市| 屯昌县| 太白县| 华蓥市| 桂阳县| 伊金霍洛旗|